Status:
RECRUITING
An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies
Lead Sponsor:
Bayer
Conditions:
Vasomotor Symptoms (VMS) Associated With Menopause
Eligibility:
FEMALE
40-65 years
Brief Summary
This is an observational study to learn more about vasomotor symptoms (VSM) burden and treatment patterns in menopausal women before and after participating in OASIS studies. In this study, data from...
Eligibility Criteria
Inclusion
- Patients in the US who participated in one of the three OASIS trials for patients with moderate-to-severe VMS related to menopause.
- Patients who confirmed interest in being contacted for further study communication
- Patients who consent to be included in the registry, complete the pre-OASIS trial survey, and agree to be tokenized so that their anonymized real-world data can be accessed
Exclusion
- None
Key Trial Info
Start Date :
April 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2029
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06949553
Start Date
April 30 2025
End Date
February 15 2029
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bayer US
Whippany, New Jersey, United States, 07981